NCT01352117 2019-11-14
REACT-KS
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Phase 3 Completed
Clinical Trials
1 trialsSarcoma, Kaposi × Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination × Clear all